Cargando…

Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery

OBJECTIVE: To introduce a novel technology currently under final development before regulatory approvals for the furtherment of cataract surgery, using the FemtoMatrix(®) laser system, and to demonstrate its safety and efficacy as compared to standard ultrasound phacoemulsification. METHODS: Thirty-...

Descripción completa

Detalles Bibliográficos
Autores principales: de Saint Jean, Amélie, Dufournel, Damien, Stodulka, Pavel, Romano, Fabrice, Bernard, Aurélien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149859/
https://www.ncbi.nlm.nih.gov/pubmed/37138745
http://dx.doi.org/10.3389/fmed.2023.1157486
_version_ 1785035237448744960
author de Saint Jean, Amélie
Dufournel, Damien
Stodulka, Pavel
Romano, Fabrice
Bernard, Aurélien
author_facet de Saint Jean, Amélie
Dufournel, Damien
Stodulka, Pavel
Romano, Fabrice
Bernard, Aurélien
author_sort de Saint Jean, Amélie
collection PubMed
description OBJECTIVE: To introduce a novel technology currently under final development before regulatory approvals for the furtherment of cataract surgery, using the FemtoMatrix(®) laser system, and to demonstrate its safety and efficacy as compared to standard ultrasound phacoemulsification. METHODS: Thirty-three patients with bilateral cataracts were operated on with one eye undergoing PhotoEmulsification(®) treatment on the FemtoMatrix(®) device and the contralateral eye receiving the control procedure, i.e., standard ultrasound phacoemulsification treatment. The number of “zero-phaco” procedures (denoting that I/A alone was sufficient to aspirate the lens fragments and that no ultrasound energy was needed) was recorded and Effective Phaco Time (EPT) values were compared. The patient follow-up was 3 months. RESULTS: Thirty-three eyes from a population with a mean cataract grade of 2.6 were treated on the FemtoMatrix(®), of which 29 were “zero-phaco” (88%). All patients were operated on by a single surgeon who was a relative novice to the technology (63 patients treated prior to this study). Conversely, of the 33 fellow eyes who underwent standard ultrasound phacoemulsification, none were zero-phaco (0%) - all required varying degrees of ultrasound energy to make lens aspiration possible. The mean EPT was significantly lower in the PhotoEmulsification(®) laser group (0.2 ± 0.8 s) than in the phaco group (1.3 ± 1.2 s) (p < 0.0001). The safety profiles of the two procedures were comparable, with no device-related adverse events noted. CONCLUSION: FemtoMatrix(®) is a promising femtosecond laser platform that, when compared to phacoemulsification, significantly decreases or eliminates EPT altogether. The system is used to perform PhotoEmulsification(®), making zero-phaco cataract procedures feasible including in high-grade cataracts (>3). It enables personalized treatment by automatically measuring and adapting the laser energy required to obtain the most efficient cutting of the crystalline lens. This new technology appears to be safe and effective in cataract surgery.
format Online
Article
Text
id pubmed-10149859
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101498592023-05-02 Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery de Saint Jean, Amélie Dufournel, Damien Stodulka, Pavel Romano, Fabrice Bernard, Aurélien Front Med (Lausanne) Medicine OBJECTIVE: To introduce a novel technology currently under final development before regulatory approvals for the furtherment of cataract surgery, using the FemtoMatrix(®) laser system, and to demonstrate its safety and efficacy as compared to standard ultrasound phacoemulsification. METHODS: Thirty-three patients with bilateral cataracts were operated on with one eye undergoing PhotoEmulsification(®) treatment on the FemtoMatrix(®) device and the contralateral eye receiving the control procedure, i.e., standard ultrasound phacoemulsification treatment. The number of “zero-phaco” procedures (denoting that I/A alone was sufficient to aspirate the lens fragments and that no ultrasound energy was needed) was recorded and Effective Phaco Time (EPT) values were compared. The patient follow-up was 3 months. RESULTS: Thirty-three eyes from a population with a mean cataract grade of 2.6 were treated on the FemtoMatrix(®), of which 29 were “zero-phaco” (88%). All patients were operated on by a single surgeon who was a relative novice to the technology (63 patients treated prior to this study). Conversely, of the 33 fellow eyes who underwent standard ultrasound phacoemulsification, none were zero-phaco (0%) - all required varying degrees of ultrasound energy to make lens aspiration possible. The mean EPT was significantly lower in the PhotoEmulsification(®) laser group (0.2 ± 0.8 s) than in the phaco group (1.3 ± 1.2 s) (p < 0.0001). The safety profiles of the two procedures were comparable, with no device-related adverse events noted. CONCLUSION: FemtoMatrix(®) is a promising femtosecond laser platform that, when compared to phacoemulsification, significantly decreases or eliminates EPT altogether. The system is used to perform PhotoEmulsification(®), making zero-phaco cataract procedures feasible including in high-grade cataracts (>3). It enables personalized treatment by automatically measuring and adapting the laser energy required to obtain the most efficient cutting of the crystalline lens. This new technology appears to be safe and effective in cataract surgery. Frontiers Media S.A. 2023-04-17 /pmc/articles/PMC10149859/ /pubmed/37138745 http://dx.doi.org/10.3389/fmed.2023.1157486 Text en Copyright © 2023 de Saint Jean, Dufournel, Stodulka, Romano and Bernard. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
de Saint Jean, Amélie
Dufournel, Damien
Stodulka, Pavel
Romano, Fabrice
Bernard, Aurélien
Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery
title Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery
title_full Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery
title_fullStr Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery
title_full_unstemmed Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery
title_short Comparison of ultrasound phacoemulsification and FemtoMatrix(®) PhotoEmulsification(®) cataract surgery
title_sort comparison of ultrasound phacoemulsification and femtomatrix(®) photoemulsification(®) cataract surgery
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149859/
https://www.ncbi.nlm.nih.gov/pubmed/37138745
http://dx.doi.org/10.3389/fmed.2023.1157486
work_keys_str_mv AT desaintjeanamelie comparisonofultrasoundphacoemulsificationandfemtomatrixphotoemulsificationcataractsurgery
AT dufourneldamien comparisonofultrasoundphacoemulsificationandfemtomatrixphotoemulsificationcataractsurgery
AT stodulkapavel comparisonofultrasoundphacoemulsificationandfemtomatrixphotoemulsificationcataractsurgery
AT romanofabrice comparisonofultrasoundphacoemulsificationandfemtomatrixphotoemulsificationcataractsurgery
AT bernardaurelien comparisonofultrasoundphacoemulsificationandfemtomatrixphotoemulsificationcataractsurgery